GLICLAZIDE S.R. TABLETS

60 mg
  • Therapy of maturity onset Diabetes Mellitus (non-insulin-dependant or Type II), where dietary management alone has been insufficient.
    (Gliclazide is an oral hypoglycemic used for the control of blood glucose in people with Diabetes Mellitus (non-insulin-dependant or Type II). It is used when diet, exercise, and weight reduction have not been found to control blood glucose well enough without medication. Gliclazide increases the amount of insulin released by the pancreas and helps the body use insulin more efficiently.)
  • Posology: once daily
  • Dossier available, including bioequivalence studies vs Diamicron LM (Servier, France) 
  • CPP for exportation available
  • Available for worldwide applications
 
LEGENDA :
Gliclazide S.R. tablets (60 mg) means Gliclazide Slow Release or Sustained Release tablets (60 mg) and corresponds to Gliclazide P.R., i.e. Prolonged Release, tablets, as well as to Gliclazide E.R. or X.R., i.e. Extended Release, tablets, and to Gliclazide M.R., i.e. Modified Release, tablets (60 mg) .
Do you need more information?
Company:
* Name and Surname:
Address:
City:
District:
Cap:
Country:
* E-mail:
Phone:
Fax:
Write for special requests:
Mandatory Fields *
Valpharma S.p.A. - Via Ranco, 112 - 47899 - Serravalle - Tel. +378 0549 900936 - E-mail: valpharma@valpharma.com- Privacy Policy - C.o.E. SM02686
Credits TITANKA! Spa © 2015